You are here: Industry Insights > COVID-19

News List

ARCA Submits IND for AB201 in COVID-19 contractpharma
September 22, 2020
AB201, a Phase IIb-ready recombinant protein aims to address the pathologies caused by viral infections from multiple aspects.
ARCA biopharma submits IND application to US FDA for a potential COVID-19 treatment expresspharma
September 22, 2020
Pending FDA feedback, ARCA anticipates initiating the Phase 2b portion of a sequential Phase 2b/3 clinical evaluation of AB201 in the fourth quarter of this year.
Baricitinib, Remdesivir Trial Reduces Recovery Time in Hospitalized COVID-19 Patients americanpharmaceuticalreview
September 21, 2020
Eli Lilly and Company and Incyte announced initial data emerging from the Adaptive COVID-19 Treatment Trial (ACTT-2) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
Russia authorises first Covid-19 drug Coronavir for sale in pharmacies pharmaceutical-technology
September 21, 2020
Russia has granted marketing authorisation for R-Pharm’s Covid-19 prescription drug, Coronavir, to treat outpatients with mild to moderate infection.
Online-offline pharmacy collaboration will lead the future: Industry experts expresspharma
September 21, 2020
They inform that it is the best way to co-drive value for consumers and drive a fundamental shift in healthcare delivery.
Indian pharma industry will be among the first to develop and supply low cost vaccines for COVID-19: Gowda expresspharma
September 21, 2020
He also said that the bulk drug and medical device parks will attract cumulative investment of Rs 78000 crores.
Experimental drug blocks COVID-19 viral entry into lung cells expresspharma
September 21, 2020
Researchers at NYU Grossman School of Medicine made changes to a free ACE2 molecule, and then fused one part of it to a piece of an antibody, an immune system protein, with the goal of strengthening its antiviral effect.
Developing herd immunity without pharma interventions may have detrimental consequences: Choubey expresspharma
September 21, 2020
Thirteen clinical trials of repurposed drugs have been undertaken to build a portfolio of therapeutic options for COVID-19 patients, said the Minister.
Scientists find new drug that may be able to prevent or mitigate severe COVID-19 infection expresspharma
September 21, 2020
Repurposing the 4-PBA anti-stress drug could modulate such cellular stress and curb mortality caused by respiratory failure derived from cellular stress, said researchers.
Melior Pharmaceuticals awarded grant for advancing pulmonary therapeutic in Covid-19 phase 2 clinical trial pharmaceutical-business-review
September 18, 2020
Melior Pharmaceuticals has been awarded a grant from the Commonwealth of Pennsylvania’s COVID-19 Vaccines, Treatments and Therapies (CV-VTT) Program, which is designed to support rapid advancement of promising COVID-19 therapies.